1160308--3/16/2006--ADVENTRX_PHARMACEUTICALS

related topics

{product, candidate, development}

{product, liability, claim}

{property, intellectual, protect}

{personnel, key, retain}

{competitive, industry, competition}

{capital, credit, financial}

It is uncertain that we will have access to future capital. We are not certain that we will be successful in the development of our drug candidates. Positive results in preclinical and clinical trials do not ensure that future clinical trials will be successful or that drug candidates will receive all necessary regulatory approvals for the marketing, distribution or sale of such drug candidates. We will face intense competition from other companies in the pharmaceutical industry. There is no assurance that our products will have market acceptance. The unavailability of health care reimbursement for any of our products will likely adversely impact our ability to effectively market such products and whether health care reimbursement will be available for any of our products is uncertain. Uncertainties related to health care reform measures may affect our success Further testing of our drug candidates will be required and there is no assurance of FDA approval. Our success will depend on licenses and proprietary rights we receive from other parties, and on any patents we may obtain. Our license agreements can be terminated in the event of a breach. Protecting our proprietary rights is difficult and costly. We may be unable to retain skilled personnel and maintain key relationships. We currently have no sales capability, and limited marketing capability. We do not have manufacturing capabilities and may not be able to efficiently develop manufacturing capabilities or contract for such services from third parties on commercially acceptable terms. We are dependent in part on third parties for drug development and research facilities. In the future, we anticipate that we will need to obtain additional or increased product liability insurance coverage and it is uncertain that such increased or additional insurance coverage can be obtained on commercially reasonable terms.

Full 10-K form ▸

1160308--3/16/2006--ADVENTRX_PHARMACEUTICALS_INC